ABSTRACT
The high incidence of gastric cancer (GC) and its consequent mortality rate severely threaten human's health. It is not frequently diagnosed until a relatively advanced stage. Surgery is the only potentially curative treatment. Thus, early screening and diagnosis are critical for patients with GC. The tumor marker assays used currently for detecting GC are simple and rapid, but the usage is limited by its low sensitivity and specificity. Here, we provide a brief description of some new potential markers and new biotechnological methods for the diagnosis of GC, hoping to find out more effective approaches for early detection of GC.
KEYWORDS:
Acknowledgments
This study was supported by the National Natural Science Foundation of China (81001454), the fundamental Research Funds for the Central University (XDJK2014B024, XDJK2015A005), and the Research Fund for the Doctoral Program of Southwest University, China (SWU109036).
Declaration of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.